• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SCL
Click for more information
0.00% 48.0¢

SCHROLE GROUP LTD - Announcements

Market Cap $17.25M  ! watchlist Created with Sketch. Add to my watchlist

Schrole Group Limited is an Australia-based company, which is a provider of accredited... Schrole Group Limited is an Australia-based company, which is a provider of accredited training and global human resources (HR) software-as-a-service (SaaS). The Company's Schrole HR is a complete human resources SaaS solution, combining recruitment, background checks, onboarding, relief teacher management, and professional development. It includes Schrole Connect, Schrole Events, Schrole Cover, Schrole Verify, Schrole Develop, and Schrole Engage. Schrole Connect is an advanced recruitment and applicant tracking application. Schrole Events is a part of the Connect module, provides online recruitment events. Schrole Cover is a cloud-based software platform that engages relief staff at the touch of a button. Schrole Verify provides background screening to the international schools’ sector. Schrole Develop provides accredited professional development solutions contextualized to client needs. Schrole Engage provides onboarding and contract management software for schools. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
SCL Investor Presentation13/03/19
SCL Preliminary Final ReportPRICE SENSITIVE01/03/19
SCL Appendix 4C - quarterlyPRICE SENSITIVE31/01/19
SCL Appendix 3B13/11/18
SCL Appendix 4C and Quarterly Summary of ActivitiesPRICE SENSITIVE31/10/18
SCL Schrole reports continuing strong sales across key productsPRICE SENSITIVE25/10/18
SCL Change of Director's Interest Notice17/10/18
SCL Release of options from escrow02/10/18
SCL Appendix 3B - Performance Share Series A Conversion27/09/18
SCL ISS-Schrole Advantage Software Platform Goes LivePRICE SENSITIVE27/09/18
SCL Schrole executes Alliance Agreement with ISSPRICE SENSITIVE03/09/18
SCL Half Yearly Report and AccountsPRICE SENSITIVE31/08/18
SCL Appendix 4C and Quarterly Summary of ActivitiesPRICE SENSITIVE31/07/18
SCL Achieving strong renewal sales for 2018/2019 school yearPRICE SENSITIVE25/07/18 download Created with Sketch. 331.94KB
SCL Schrole to present at RISE Investor Conference in Hong Kong06/07/18 download Created with Sketch. 3.88MB
SCL Change of Director's Interest Notice04/07/18 download Created with Sketch. 258.16KB
SCL Appendix 3B - Issue of Performance Rights to Employees03/07/18 download Created with Sketch. 417.68KB
SCL Cleansing ProspectusPRICE SENSITIVE03/07/18 download Created with Sketch. 234.13KB
SCL First sale of ISS-Schrole Advantage to international schoolsPRICE SENSITIVE26/06/18 download Created with Sketch. 338.57KB
SCL Change of Director's Interest Notice05/06/18 download Created with Sketch. 317.87KB
SCL Results of Meeting23/05/18 download Created with Sketch. 224.7KB
SCL First sale for Schrole Verify background screening solutionPRICE SENSITIVE22/05/18 download Created with Sketch. 334.25KB
SCL Appendix 4C and Quarterly Summary of ActivitiesPRICE SENSITIVE30/04/18
SCL Notice of Annual General Meeting/Proxy Form23/04/18
SCL Investor Presentation09/04/18
SCL Schrole enters into strategic alliance with ISSPRICE SENSITIVE05/04/18
SCL Trading HaltPRICE SENSITIVE03/04/18
SCL Appendix 4G03/04/18
SCL Annual Financial Report03/04/18
SCL Schrole Teacher Placement Research Program with ECUPRICE SENSITIVE27/03/18
SCL Preliminary Final Report and Summary of Activities28/02/18
SCL Appedix 4E Preliminary Final ReportPRICE SENSITIVE28/02/18
SCL Appendix 4C - quarterlyPRICE SENSITIVE31/01/18
SCL Schrole Signs Formal Agreement with First AdvantagePRICE SENSITIVE27/12/17
SCL Launch of Schrole Verify & Partnership with First AdvantagePRICE SENSITIVE29/11/17
SCL Joint Company Secretary Resignation24/11/17
SCL Schrole Commercial Partnership with SentralPRICE SENSITIVE21/11/17
SCL Schrole Group Ltd Investor Presentation09/11/17
SCL Details of Company Address08/11/17
SCL Schrole Operational UpdatePRICE SENSITIVE17/10/17
SCL Schrole commences trading on ASX12/10/17
SCL Reinstatement to Official QuotationPRICE SENSITIVE11/10/17
SCL Schrole awarded tender for hospital contract11/10/17
SCL Constitution11/10/17
SCL Capital Structure and Securities Subject to Escrow11/10/17
SCL Securities Trading Policy11/10/17
SCL Annual Report of Schrole Operations Ltd 30 June 201711/10/17
SCL Annual Report of Schrole Group Limited 31 December 201611/10/17
SCL Annual Report of Schrole Pty Ltd 30 June 201611/10/17
SCL Annual Report of Schrole Pty Ltd 30 June 201511/10/17
SCL Annual Report of ETAS (WA) Pty Ltd 30 June 201511/10/17
SCL Top 20 Holders11/10/17
SCL Distribution Schedule11/10/17
SCL Information Form and Checklist11/10/17
SCL ASX Listing Application and Agreement11/10/17
SCL Pre-Reinstatement Disclosure11/10/17
SCL ASX Notice - Reinstatement to Official Quotation11/10/17
SCL Final Director's Interest Notice x 306/10/17
SCL Initial Director's Interest Notice x 406/10/17
SCL Appendix 3B06/10/17
SCL Schrole Acquisition Completion and Capital Raising06/10/17
SCL Deed of Company Arrangement Effectuated04/10/17
SCL Change of Company Name03/10/17
SCL Consolidation of Capital Completed25/09/17
SCL Corporate update19/09/17
SCL Results of Annual General Meeting 2015 and 201614/09/17
SCL Consolidation/Split - AQU08/09/17
SCL Notification of reorganisation of capital07/09/17
SCL Half Yearly Report and Accounts 201701/09/17
SCL Suspension from Official Quotation - Annual Listing Fees22/08/17
SCL Aquaint Prospectus for Capital Raise21/08/17
SCL Prospectus21/08/17
SCL Notice of Annual General Meeting (2015)15/08/17
SCL Notice of Annual General Meeting (2016)15/08/17
SCL Acquisition Announcement13/06/17
SCL Full Year Statutory Accounts07/06/17
SCL Half Year Accounts07/06/17
SCL Full Year Statutory Accounts07/06/17
SCL Half Year Accounts07/06/17
SCL Change of Auditor01/03/17
SCL Final Director's Interest Notice05/12/16
SCL Final Director's Interest Notice05/12/16
SCL Final Director's Interest Notice05/12/16
SCL Initial Director's Interest Notice05/12/16
SCL Initial Director's Interest Notice05/12/16
SCL Initial Director's Interest Notice05/12/16
SCL Director Appointment/Resignation05/12/16
SCL Deed of Company Arrangement Executed-AQU.AX 19/09/16
SCL Notice to shareholders re Deed of Company Arrangement-AQU.AX 28/08/16
SCL Notice to shareholders re Deed of Company Arrangement-AQU.AX 26/08/16
SCL Extension to Administration convening period-AQU.AX 21/07/16
SCL Appointment of Voluntary Administrators-AQU.AX 15/06/16
SCL Appendix 3B-AQU.AX 26/05/16
SCL Appendix 3B-AQU.AX 19/05/16
SCL Response to ASX queries-AQU.AX 29/04/16
SCL Results of Meeting-AQU.AX 12/04/16
SCL EGM Concall Details-AQU.AX 08/04/16
SCL Appendix 3B31/03/16
SCL Completion of acquisition of land in laos29/03/16
SCL Resignation of Secretary & Change of Registered Office18/03/16
SCL Investor Presentation
13/03/19
SCL Preliminary Final Report
01/03/19PRICE SENSITIVE
SCL Appendix 4C - quarterly
31/01/19PRICE SENSITIVE
SCL Appendix 3B
13/11/18
SCL Appendix 4C and Quarterly Summary of Activities
31/10/18PRICE SENSITIVE
SCL Schrole reports continuing strong sales across key products
25/10/18PRICE SENSITIVE
SCL Change of Director's Interest Notice
17/10/18
SCL Release of options from escrow
02/10/18
SCL Appendix 3B - Performance Share Series A Conversion
27/09/18
SCL ISS-Schrole Advantage Software Platform Goes Live
27/09/18PRICE SENSITIVE
SCL Schrole executes Alliance Agreement with ISS
03/09/18PRICE SENSITIVE
SCL Half Yearly Report and Accounts
31/08/18PRICE SENSITIVE
SCL Appendix 4C and Quarterly Summary of Activities
31/07/18PRICE SENSITIVE
SCL Achieving strong renewal sales for 2018/2019 school year
25/07/18PRICE SENSITIVE download Created with Sketch. 331.94KB
SCL Schrole to present at RISE Investor Conference in Hong Kong
06/07/18 download Created with Sketch. 3.88MB
SCL Change of Director's Interest Notice
04/07/18 download Created with Sketch. 258.16KB
SCL Appendix 3B - Issue of Performance Rights to Employees
03/07/18 download Created with Sketch. 417.68KB
SCL Cleansing Prospectus
03/07/18PRICE SENSITIVE download Created with Sketch. 234.13KB
SCL First sale of ISS-Schrole Advantage to international schools
26/06/18PRICE SENSITIVE download Created with Sketch. 338.57KB
SCL Change of Director's Interest Notice
05/06/18 download Created with Sketch. 317.87KB
SCL Results of Meeting
23/05/18 download Created with Sketch. 224.7KB
SCL First sale for Schrole Verify background screening solution
22/05/18PRICE SENSITIVE download Created with Sketch. 334.25KB
SCL Appendix 4C and Quarterly Summary of Activities
30/04/18PRICE SENSITIVE
SCL Notice of Annual General Meeting/Proxy Form
23/04/18
SCL Investor Presentation
09/04/18
SCL Schrole enters into strategic alliance with ISS
05/04/18PRICE SENSITIVE
SCL Trading Halt
03/04/18PRICE SENSITIVE
SCL Appendix 4G
03/04/18
SCL Annual Financial Report
03/04/18
SCL Schrole Teacher Placement Research Program with ECU
27/03/18PRICE SENSITIVE
SCL Preliminary Final Report and Summary of Activities
28/02/18
SCL Appedix 4E Preliminary Final Report
28/02/18PRICE SENSITIVE
SCL Appendix 4C - quarterly
31/01/18PRICE SENSITIVE
SCL Schrole Signs Formal Agreement with First Advantage
27/12/17PRICE SENSITIVE
SCL Launch of Schrole Verify & Partnership with First Advantage
29/11/17PRICE SENSITIVE
SCL Joint Company Secretary Resignation
24/11/17
SCL Schrole Commercial Partnership with Sentral
21/11/17PRICE SENSITIVE
SCL Schrole Group Ltd Investor Presentation
09/11/17
SCL Details of Company Address
08/11/17
SCL Schrole Operational Update
17/10/17PRICE SENSITIVE
SCL Schrole commences trading on ASX
12/10/17
SCL Reinstatement to Official Quotation
11/10/17PRICE SENSITIVE
SCL Schrole awarded tender for hospital contract
11/10/17
SCL Constitution
11/10/17
SCL Capital Structure and Securities Subject to Escrow
11/10/17
SCL Securities Trading Policy
11/10/17
SCL Annual Report of Schrole Operations Ltd 30 June 2017
11/10/17
SCL Annual Report of Schrole Group Limited 31 December 2016
11/10/17
SCL Annual Report of Schrole Pty Ltd 30 June 2016
11/10/17
SCL Annual Report of Schrole Pty Ltd 30 June 2015
11/10/17
SCL Annual Report of ETAS (WA) Pty Ltd 30 June 2015
11/10/17
SCL Top 20 Holders
11/10/17
SCL Distribution Schedule
11/10/17
SCL Information Form and Checklist
11/10/17
SCL ASX Listing Application and Agreement
11/10/17
SCL Pre-Reinstatement Disclosure
11/10/17
SCL ASX Notice - Reinstatement to Official Quotation
11/10/17
SCL Final Director's Interest Notice x 3
06/10/17
SCL Initial Director's Interest Notice x 4
06/10/17
SCL Appendix 3B
06/10/17
SCL Schrole Acquisition Completion and Capital Raising
06/10/17
SCL Deed of Company Arrangement Effectuated
04/10/17
SCL Change of Company Name
03/10/17
SCL Consolidation of Capital Completed
25/09/17
SCL Corporate update
19/09/17
SCL Results of Annual General Meeting 2015 and 2016
14/09/17
SCL Consolidation/Split - AQU
08/09/17
SCL Notification of reorganisation of capital
07/09/17
SCL Half Yearly Report and Accounts 2017
01/09/17
SCL Suspension from Official Quotation - Annual Listing Fees
22/08/17
SCL Aquaint Prospectus for Capital Raise
21/08/17
SCL Prospectus
21/08/17
SCL Notice of Annual General Meeting (2015)
15/08/17
SCL Notice of Annual General Meeting (2016)
15/08/17
SCL Acquisition Announcement
13/06/17
SCL Full Year Statutory Accounts
07/06/17
SCL Half Year Accounts
07/06/17
SCL Full Year Statutory Accounts
07/06/17
SCL Half Year Accounts
07/06/17
SCL Change of Auditor
01/03/17
SCL Final Director's Interest Notice
05/12/16
SCL Final Director's Interest Notice
05/12/16
SCL Final Director's Interest Notice
05/12/16
SCL Initial Director's Interest Notice
05/12/16
SCL Initial Director's Interest Notice
05/12/16
SCL Initial Director's Interest Notice
05/12/16
SCL Director Appointment/Resignation
05/12/16
SCL Deed of Company Arrangement Executed-AQU.AX
19/09/16
SCL Notice to shareholders re Deed of Company Arrangement-AQU.AX
28/08/16
SCL Notice to shareholders re Deed of Company Arrangement-AQU.AX
26/08/16
SCL Extension to Administration convening period-AQU.AX
21/07/16
SCL Appointment of Voluntary Administrators-AQU.AX
15/06/16
SCL Appendix 3B-AQU.AX
26/05/16
SCL Appendix 3B-AQU.AX
19/05/16
SCL Response to ASX queries-AQU.AX
29/04/16
SCL Results of Meeting-AQU.AX
12/04/16
SCL EGM Concall Details-AQU.AX
08/04/16
SCL Appendix 3B
31/03/16
SCL Completion of acquisition of land in laos
29/03/16
SCL Resignation of Secretary & Change of Registered Office
18/03/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
48.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $17.25M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
SCL (ASX) Chart

Top Stories

White Cliff Minerals bags lucrative Canadian deposit at Rae Copper

White Cliff Minerals (ASX:WCN) has acquired 100% of licence L-2797 from Victoria Copper at the substantial Danvers copper deposit in Canada.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.